Editorial: Understanding convergent evasion mechanisms in cancer and chronic infection: implications for immunotherapy

Front Immunol. 2024 Jul 1:15:1450555. doi: 10.3389/fimmu.2024.1450555. eCollection 2024.

Hakim Echchannaoui^{1

2}, Matthieu Perreau³, Hansjörg Schild^{4

5}, Matthias Theobald^{1

2

4}

¹ Department of Hematology and Medical Oncology, University Cancer Center (UCT), University Medical Center (UMC) of the Johannes Gutenberg University, Mainz, Germany.
² German Cancer Consortium (DKTK), Partner site Frankfurt/Mainz, Mainz, Germany.
³ Division of Immunology and Allergy, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
⁴ Institute of Immunology, UMC of the Johannes Gutenberg University, Mainz, Germany.
⁵ Helmholtz Institute Translational Oncology (HI-TRON), Mainz, Germany.

No abstract available

Keywords: chronic infection; cutting edge technologies; immune evasion; immunotherapy; metabolism; tumor microenvironment.

Publication types